FDA Reclassifies Knee Joints

Article

WASHINGTON -- The Food and Drug Administration (FDA) has reclassified two fixed-bearing knee joint prostheses, the patellofemorotibial and the femorotibial (uni-compartmental) metal/polymer porous-coated uncemented prosthesis, from class III devices (i.e., premarket approval) to class II devices (i.e., special controls).

The special control that will apply to the patellofemorotibial prosthesis, used for whole knee joint replacement, and the femorotibial prosthesis, used for partial knee joint replacement, is titled "Class II Special Controls Guidance Document: Knee Joint Patellofemorotibial and Femorotibial Metal/Polymer Porous-coated Uncemented Prostheses; Guidance for Industry and FDA."

The FDA reasoned that special controls, in addition to general controls, will provide reasonable assurance of the safety and effectiveness of the devices. The rule was effective March 24, 2003. For more information, visit http://www.fda.gov/OHRMS/DOCKETS/98fr/ 03-6857.html.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
COVID-19 infection (Adobe Stock327378972 by rost9)
Swarm of Mosquitoes on Green Background Disease Carriers Insect Infestation  (Adobe Stock 1609688034 by Amith)
Structural detail of Hepatitis B virus on blue-green background. 3D illustration (Adobe Stock 239268660 by Destina)
© 2025 MJH Life Sciences

All rights reserved.